Mr. Chen has served as counsel to:
- FountainVest Partners in number of significant Greater China transactions, including its investments in 360 Finance, Laobaixing Pharmacy, Maoyan Entertainment, Meituan-Dianping, and Fangdd.com
- Horizons Ventures, the technology investment arm of Li Ka-Shing, in a number of its private and public company investments, including Zoom Video Communications, Impossible Foods, Airwallex, ChromaDex Corporation, Celsius Holdings and Perfect Day
- Hillhouse Capital and its affiliates on a number of its investments in China, Hong Kong and the U.S.
- LionRock Capital in connection with its acquisition of a majority stake in leading shoe manufacturer and retailer Clarks
- LionRock Capital in connection with investment in the football club Inter Milan
- FountainVest Partners in the sale of its interests in Focus Media, a leading digital marketing company listed on the Shenzhen Stock Exchange, to the Alibaba Group
- FountainVest Partners in its China joint venture with WME | IMG, a global sports, fashion and entertainment talent management company, together with Sequoia Capital China and Tencent
- FountainVest Partners, and its portfolio company, Trusted Doctors, in its merger with Tencent Doctorwork, a medical unit of Tencent Holdings
- TKK Symphony in the de-SPAC acquisition of Glory Star New Media Group, a leading mobile entertainment platform in China
- ePak Resources in its acquisition by One Equity Partners
- FountainVest Partners in connection with its going private acquisition of Chinese online career platform Zhaopin Limited, together with Hillhouse Capital and SEEK International*
- ZQ Capital in its acquisition of Angiotech Pharmaceuticals, Inc., a medical device manufacturer*
- ZQ Capital in its PIPE investment in NYSE-listed Nu Skin Enterprises*
- TOM Group Limited, in their investments in WeLab Holdings (WeLend) and Rubikloud Technologies Inc.*
- China Media Capital and FountainVest Partners in their investment in the Greater China business of large-screen movie exhibitor IMAX Corp. and the sale of their shares in the Hong Kong IPO of IMAX China
- The buyer consortium (including The Carlyle Group, FountainVest Partners, and CITIC Capital Partners) in connection with the US$3.7 billion acquisition of Focus Media, China’s then-largest leveraged buy-out (awarded “Global M&A Deal of the Year: China Private Equity” by The American Lawyer (2014) and “Private Equity Deal of the Year” by IFLR (2014) and China Law & Practice (2013))*
* Denotes experience prior to joining Goodwin.
陈律师曾处理的交易包括：
- 代表方源资本处理其在大中华地区的多项投资，包括对360金融、老百姓大药房、猫眼娱乐、美团点评和房多多等的投资。
- 代表李嘉诚旗下的维港投资处理其多宗私人公司及上市公司投资，包括对Zoom视频通讯公司、Impossible Foods、空中云汇（Airwallex）、ChromaDex、摄氏控股（Celsius Holdings）和Perfect Day进行的投资。
- 代表高瓴资本及其关联机构办理其在中国、香港和美国的多项投资。
- 代表莱恩资本收购领先鞋类制造商和零售商Clarks的多数股权。
- 代表莱恩资本对国际米兰（Inter Milan）足球俱乐部进行投资。
- 代表方源资本向阿里巴巴集团出售其持有的分众传媒（一家在深圳证券交易所上市的领先数字营销公司）的权益。
- 代表方源资本联合红杉资本和腾讯与全球体育、时尚和娱乐经纪公司WME-IMG在中国设立合资公司。
- 代表方源资本及其投资组合公司杏仁医生（Trusted Doctors）与腾讯控股旗下医疗子公司企鹅医生（Tencent Doctorwork）进行合并。
- 代表TKK Symphony收购中国知名移动娱乐服务商耀世星辉媒体集团控股。
- 代表意发资源（ePAK）收购One Equity Partners。
- 代表方源资本，处理其联合高瓴资本及SEEK International对中国招聘网站智联招聘进行私有化的交易。*
- 代表倍哲资本收购医疗器械制造商Angiotech Pharmaceuticals。*
- 代表倍哲资本对纽约上市的如新企业（Nu Skin Enterprises）进行的私人投资公开股票（PIPE）交易提供法律咨询。*
- 代表TOM集团投资于WeLab Holdings（WeLend）和Rubikloud Technologies Inc.。*
- 代表华人文化产业投资基金和方源资本投资于大屏幕电影参展商IMAX Corp.的大中华业务（该交易获《亚洲创业投资期刊》评为2014年度“最佳中型交易”）以及在IMAX中国的香港首次公开募股中出售持有的股份。*
- 为买方银团（由凯雷、方源资本和中信资本组成）提供咨询服务，协助处理其作价37亿美元收购分众传媒控股有限公司（纳斯达克上市代号：FMCN）的事宜。此私有化交易是中国历来最大型的杠杆收购（该交易获《美国律师》杂志评为2014年度“全球年度最佳中国私募股权并购交易”，并获《全球金融法律评论》杂志和《中国法律商务》杂志分别评为2014年度及2013年度“最佳私募股权交易”。*
*代表加入高赢之前办理的交易